Cibus
CBUS----
Cibus (CBUS)
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve highe...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Cibus Analyst Rating
View MoreForecast & Rating
Jul 23, 2026Price forecast
$14.67762.75%
Forecast & RatingBuy
3analysts
- Strong buy66.67%
- Buy0.00%
- Hold33.33%
- Sell0.00%
- Strong sell0.00%
News
- Price Alert · Jul 16 at 12:57 PM
U.S. stock market midday update: Cibus down 11.54%, acquisition boosts financial metrics, but the market remains concerned about future profitability
- benzinga_article · Jul 14 at 12:05 PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
- benzinga_article · Jul 8 at 04:05 PM
12 Health Care Stocks Moving In Wednesday's After-Market Session
- MSN · Jun 24 at 06:13 AM
At a glance: Stocks gapping down premarket
- Quartr · Jun 17 at 12:14 PM
CBUS: EU regulatory shift accelerates gene editing commercialization and royalty growth prospects
- PUBT · Jun 17 at 07:15 AM
Cibus welcomes EU move to treat non-transgenic gene-edited crops as conventional breeding
